~~<i id='05FF2145CB'><strike id='05FF2145CB'><tt id='05FF2145CB'><pre id='05FF2145CB'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

fashion

author：hotspot 2025-09-27 23:11:51 - browse：13

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： As digital health tech proliferates, a new institute aims to cut through hype

leisure time

explore

focus

explore

hotspot

Wikipedia

AdobeAstheCovid-19pandemiccontinuesintoitssecondyear,publichealthexpertsareincreasinglyconcernedthat

WSS

Juul documents reveal insider tactics on political lobbying

Latigo launches with $135 million for Vertex

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

A public scorecard can help hold safety

STAT Boddities: What happens to the brain when we get scared?

Why hospitals are withdrawing from US News rankings

explore

fashion

leisure time

Apple is now the first public company to be valued at $3 trillion

Artificial intelligence use in health care faces greater scrutiny in 2024

Tori Bowie and the unacceptable rates of Black maternal death

Why hospitals are withdrawing from US News rankings

Medicare proposal to cover medical devices draws a mixed reaction

Bernie Sanders gets little from pharma CEOs on drug prices

Novavax promises a turnaround & Lilly roils the obesity market

Cosmetics set for new safety regulation. Why the industry is on board

Activists slam private health insurers over coverage restrictions

Congress must protect the remaining independent doctors

explore

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Custom gene therapy hints at new path for rare disease treatments

Listen: Wegovy in the brain & pivotal Alzheimer's data

Google and Epic fight stronger regulation of AI in health care

Congress might make insulin pumps more accessible to the blind

focus

explore

hotspot

Wikipedia